Improving Long-Term Outcomes After Liver Transplantation

Michael R. Charlton

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Long-term survival following liver transplantation is profoundly affected by conditions unrelated to graft function. Many causes of mortality are contributed to by the metabolic syndrome. The approach to metabolic syndrome in liver transplant recipients requires consideration of transplant-specific factors, particularly immunosuppression. Enhancing long-term outcomes for liver transplant recipients necessitates minimizing the amount of immunosuppression required to prevent rejection. Studies to determine the optimal approach to minimize the impact of metabolic syndrome and complications of immunosuppression in transplant recipients are needed.

Original languageEnglish (US)
Pages (from-to)717-730
Number of pages14
JournalClinics in Liver Disease
Volume18
Issue number3
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Liver Transplantation
Immunosuppression
Transplants
Liver
Survival
Mortality
Transplant Recipients

Keywords

  • Graft rejection
  • Immunosuppression
  • Liver transplantation
  • Metabolic syndrome

ASJC Scopus subject areas

  • Hepatology

Cite this

Improving Long-Term Outcomes After Liver Transplantation. / Charlton, Michael R.

In: Clinics in Liver Disease, Vol. 18, No. 3, 2014, p. 717-730.

Research output: Contribution to journalArticle

Charlton, Michael R. / Improving Long-Term Outcomes After Liver Transplantation. In: Clinics in Liver Disease. 2014 ; Vol. 18, No. 3. pp. 717-730.
@article{7bcc665c67e34098a1f561d3953b73bb,
title = "Improving Long-Term Outcomes After Liver Transplantation",
abstract = "Long-term survival following liver transplantation is profoundly affected by conditions unrelated to graft function. Many causes of mortality are contributed to by the metabolic syndrome. The approach to metabolic syndrome in liver transplant recipients requires consideration of transplant-specific factors, particularly immunosuppression. Enhancing long-term outcomes for liver transplant recipients necessitates minimizing the amount of immunosuppression required to prevent rejection. Studies to determine the optimal approach to minimize the impact of metabolic syndrome and complications of immunosuppression in transplant recipients are needed.",
keywords = "Graft rejection, Immunosuppression, Liver transplantation, Metabolic syndrome",
author = "Charlton, {Michael R.}",
year = "2014",
doi = "10.1016/j.cld.2014.05.011",
language = "English (US)",
volume = "18",
pages = "717--730",
journal = "Clinics in Liver Disease",
issn = "1089-3261",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Improving Long-Term Outcomes After Liver Transplantation

AU - Charlton, Michael R.

PY - 2014

Y1 - 2014

N2 - Long-term survival following liver transplantation is profoundly affected by conditions unrelated to graft function. Many causes of mortality are contributed to by the metabolic syndrome. The approach to metabolic syndrome in liver transplant recipients requires consideration of transplant-specific factors, particularly immunosuppression. Enhancing long-term outcomes for liver transplant recipients necessitates minimizing the amount of immunosuppression required to prevent rejection. Studies to determine the optimal approach to minimize the impact of metabolic syndrome and complications of immunosuppression in transplant recipients are needed.

AB - Long-term survival following liver transplantation is profoundly affected by conditions unrelated to graft function. Many causes of mortality are contributed to by the metabolic syndrome. The approach to metabolic syndrome in liver transplant recipients requires consideration of transplant-specific factors, particularly immunosuppression. Enhancing long-term outcomes for liver transplant recipients necessitates minimizing the amount of immunosuppression required to prevent rejection. Studies to determine the optimal approach to minimize the impact of metabolic syndrome and complications of immunosuppression in transplant recipients are needed.

KW - Graft rejection

KW - Immunosuppression

KW - Liver transplantation

KW - Metabolic syndrome

UR - http://www.scopus.com/inward/record.url?scp=84904017012&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904017012&partnerID=8YFLogxK

U2 - 10.1016/j.cld.2014.05.011

DO - 10.1016/j.cld.2014.05.011

M3 - Article

C2 - 25017085

AN - SCOPUS:84904017012

VL - 18

SP - 717

EP - 730

JO - Clinics in Liver Disease

JF - Clinics in Liver Disease

SN - 1089-3261

IS - 3

ER -